Chris Freeman - 15 Jun 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Issuer symbol
GH
Transactions as of
15 Jun 2023
Net transactions value
-$50,960
Form type
4
Filing time
16 Jun 2023, 18:16:11 UTC
Previous filing
13 Jun 2023
Next filing
02 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +4,879 +117% $0.000000 9,040 15 Jun 2023 Direct
transaction GH COMMON STOCK Tax liability $50,960 -1,346 -15% $37.86 7,694 15 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -4,879 -33% $0.000000 9,758 15 Jun 2023 COMMON STOCK 4,879 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit vests as to 25% of the shares subject to such award on June 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of June 15, 2022, during the three-year period thereafter.
F3 Not applicable to Restricted Stock Units

Remarks:

Table I, Includes 482 shares acquired on 5/14/2022 and 488 shares acquired on 5/14/2023 under Guardant Health's Employee Stock Purchase Plan.